Cerevel Therapeutics announced the appointment of Scott M. Akamine as chief legal officer, effective May 24, 2021. An accomplished legal executive, Akamine brings significant healthcare and biopharmaceutical experience to the role. He joins the company from AEON Biopharma, Inc., where he served as general counsel and corporate secretary, overseeing legal and certain administrative functions, including business development, corporate governance, intellectual property, and compliance.